PubRank

Malcolm C Pike

Author PubWeight™ 206.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007 14.37
2 Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006 7.82
3 Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003 5.78
4 Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012 5.70
5 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
6 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010 3.93
7 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
8 Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003 3.83
9 Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006 3.62
10 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
11 Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003 3.11
12 A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007 3.08
13 National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst 2010 2.59
14 Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 2014 2.40
15 Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 2009 2.14
16 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 2.09
17 Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol 2013 2.02
18 Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013 2.01
19 Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002 2.01
20 Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol 2008 2.01
21 Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception 2010 1.96
22 Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007 1.92
23 A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 2003 1.88
24 Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 2002 1.82
25 Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 2007 1.82
26 Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 2005 1.76
27 Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 2011 1.74
28 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
29 Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 2005 1.67
30 Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 2009 1.52
31 Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab 2011 1.50
32 IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 2008 1.50
33 Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003 1.48
34 Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 2013 1.47
35 Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010 1.47
36 Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer 2013 1.45
37 Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 2007 1.44
38 Prospective Study of Alcohol Drinking, Smoking, and Pancreatitis: The Multiethnic Cohort. Pancreas 2016 1.43
39 Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol 2006 1.37
40 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
41 The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 2005 1.36
42 Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009 1.35
43 Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 2013 1.34
44 Dietary fiber and colorectal cancer risk: the multiethnic cohort study. Cancer Causes Control 2007 1.33
45 Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 2004 1.30
46 Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res 2006 1.29
47 Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 2009 1.25
48 Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet 2013 1.19
49 IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 2003 1.18
50 Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011 1.17
51 Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 2006 1.16
52 Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer 2007 1.15
53 Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr Biol 2005 1.14
54 Predictors of noncompliance in an oral contraceptive clinical trial. Contraception 2011 1.13
55 Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 2012 1.13
56 Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis 2010 1.12
57 Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One 2007 1.12
58 Invasive breast cancer incidence trends by detailed race/ethnicity and age. Int J Cancer 2011 1.12
59 Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes Control 2006 1.10
60 Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol 2013 1.10
61 Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr 2009 1.10
62 ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev 2010 1.08
63 Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev 2005 1.08
64 BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006 1.07
65 Does breast size modify the association between mammographic density and breast cancer risk? Cancer Epidemiol Biomarkers Prev 2008 1.05
66 A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr 2005 1.05
67 Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 2005 1.05
68 Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 2011 1.04
69 Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiol Biomarkers Prev 2010 1.04
70 Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control 2013 1.03
71 Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2013 1.02
72 Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) 2012 1.02
73 Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res 2009 1.01
74 Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 2012 1.00
75 CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2007 1.00
76 Association of vegetable, fruit, and grain intakes with colorectal cancer: the Multiethnic Cohort Study. Am J Clin Nutr 2008 1.00
77 Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer 2008 0.99
78 Correlation of dietary intake and colorectal cancer incidence among Mexican-American migrants: the multiethnic cohort study. Nutr Cancer 2003 0.99
79 Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer 2007 0.99
80 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
81 Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst 2014 0.98
82 Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2011 0.98
83 Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 2012 0.98
84 Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev 2005 0.97
85 A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res 2006 0.97
86 Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Res Treat 2009 0.97
87 Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer. J Clin Oncol 2007 0.95
88 Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol 2012 0.95
89 A systematic assessment of common genetic variation in CYP11A and risk of breast cancer. Cancer Res 2006 0.94
90 Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement. J Magn Reson Imaging 2013 0.94
91 Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res 2005 0.94
92 Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity. Cancer Biol Ther 2002 0.92
93 Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cancer Epidemiol Biomarkers Prev 2005 0.92
94 Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial/ethnic groups: results from the Los Angeles-Shanghai case-control study. Cancer Epidemiol Biomarkers Prev 2010 0.92
95 Ethnic differences in the use of regular mammography: the multiethnic cohort. Breast Cancer Res Treat 2008 0.92
96 Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Clin Oncol 2004 0.92
97 Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis 2011 0.92
98 Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 2004 0.92
99 Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev 2013 0.92
100 Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers. Clin Cancer Res 2007 0.91
101 A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet 2007 0.91
102 Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012 0.90
103 Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs. Lab Invest 2012 0.90
104 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
105 No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned. Hum Mol Genet 2008 0.89
106 Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 2007 0.89
107 Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008 0.89
108 Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Res Treat 2002 0.88
109 Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood 2007 0.88
110 Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women. Breast Cancer Res Treat 2009 0.88
111 Comprehensive evaluation of ESR2 variation and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.87
112 Breast cancer risk and hysterectomy status: the Multiethnic Cohort study. Cancer Causes Control 2008 0.87
113 Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Hum Mol Genet 2011 0.85
114 Alcohol consumption and endometrial cancer risk: the multiethnic cohort. Int J Cancer 2008 0.85
115 Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study. J Clin Endocrinol Metab 2009 0.85
116 Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat 2011 0.85
117 Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2002 0.84
118 Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2010 0.84
119 Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011 0.83
120 Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis. Am J Surg Pathol 2015 0.83
121 Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res 2014 0.82
122 Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutr Cancer 2011 0.82
123 Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer 2014 0.82
124 Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. Cancer Epidemiol Biomarkers Prev 2002 0.81
125 The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women. Nutr Cancer 2013 0.80
126 Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 2012 0.80
127 Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol 2016 0.80
128 Comment on "the predictive capacity of personal genome sequencing". Sci Transl Med 2012 0.79
129 Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Cancer Epidemiol Biomarkers Prev 2009 0.79
130 Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study. Cancer Epidemiol Biomarkers Prev 2013 0.79
131 Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril 2010 0.79
132 Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis 2010 0.78
133 Re: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011 0.78
134 Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception 2012 0.77
135 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
136 Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue. Urology 2005 0.77
137 Patterns of regular use of mammography--body weight and ethnicity: the Multiethnic Cohort. J Am Acad Nurse Pract 2010 0.76
138 Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011 0.75
139 Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 2016 0.75
140 Soy isoflavones for breast cancer risk reduction. Cancer Prev Res (Phila) 2012 0.75
141 Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstet Gynecol 2017 0.75